White paper
The NDC-12 Cross-Industry Pilot: Implications & Findings for the Physical Supply Chain
Read the white paper
NDC-12 Pilot Phase "1"—A continuation of the work done in Phase "0"
The transition to a uniform 12-digit National Drug Code (NDC) will reach far beyond regulatory compliance, affecting master data, product labeling, technology platforms, financial processes, and physical supply-chain operations across the pharmaceutical ecosystem. Drawing on NNIT’s cross-industry pilot, this white paper explores the practical complexities organizations may face as NDC-10 and NDC-12 products and data coexist.
In this free white paper, discover the pilot’s key findings, high-risk areas, and real-world considerations for artwork, barcodes, electronic transactions, inventory, financial settlement, and trading-partner coordination. Discover why organizations should begin assessing their processes, systems, vendors, and dependencies now to build a realistic and coordinated transformation roadmap.
This white paper discusses:
How NDC-12 will affect operations across the pharmaceutical ecosystem
Where master data, labeling, barcodes, systems, and trading-partner transactions create the greatest risks
Practical insights from cross-industry workshops and physical supply-chain simulations
Why organizations should begin their NDC-12 impact assessments and transition planning now